Life sciences still dominate new issues, though they see below-range pricing
Through the first two months of the year, 12 VC-backed stocks have debuted on the NYSE or Nasdaq
1 April 2015•2 mins read
Through the first two months of the year, 12 VC-backed stocks have debuted on the NYSE or Nasdaq
